Logo

AstraZeneca Collaborates with Gendius to Provide Diabetes Management Support for Patients in the GCC

Share this

AstraZeneca Collaborates with Gendius to Provide Diabetes Management Support for Patients in the GCC

Shots:

  • The collaboration is built on Gendius’ diabetes management platform- Intellin- which has 200-000+ downloads worldwide. With the partnership- AstraZeneca allows HCPs across the Gulf region to use Gendius’ Intellin to augment diabetes management for reducing the incidence of complications
  • The partnership is being implemented within the framework of AstraZeneca’s Emerging Markets Health Innovation Hubs initiative to bring digital- R&D and commercial industries within emerging countries for improving patients’ outcomes. Intellin is compatible with 150+ apps and connected health devices- ranging from Fitbit and Garmin devices- to more specialist blood glucose monitors and blood pressure cuffs
  • As a result of collaboration- HealthGATE platform and app to support diabetic patient care in the GCC- will be launched later this year. The HealthGATE app will work as a gateway between HCPs and patients- enabling collaboration for personalized care and the use of AI for better disease management

Click here- Click here to read full press release/ article

Ref: Gendius | Image: AstraZenca


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions